A detailed history of Captrust Financial Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 1,509,484 shares of PFE stock, worth $42.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,509,484
Previous 1,962,431 23.08%
Holding current value
$42.3 Million
Previous $56.5 Million 25.86%
% of portfolio
0.14%
Previous 0.2%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $11.7 Million - $13.5 Million
-452,947 Reduced 23.08%
1,509,484 $41.9 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $19.2 Million - $25 Million
-735,293 Reduced 27.26%
1,962,431 $56.5 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $5.56 Million - $6.5 Million
173,173 Added 6.86%
2,697,724 $89.5 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $34.1 Million - $39.5 Million
945,396 Added 59.87%
2,524,551 $92.6 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $1.79 Million - $2.33 Million
45,404 Added 2.96%
1,579,155 $64.4 Million
Q4 2022

Feb 15, 2023

BUY
$41.75 - $54.5 $3.26 Million - $4.25 Million
78,024 Added 5.36%
1,533,751 $78.6 Million
Q3 2022

Nov 16, 2022

BUY
$43.76 - $53.42 $6.8 Million - $8.3 Million
155,373 Added 11.95%
1,455,727 $63.7 Million
Q2 2022

Aug 23, 2022

SELL
$46.53 - $55.17 $4.43 Million - $5.25 Million
-95,201 Reduced 6.82%
1,300,354 $68.2 Million
Q2 2022

Aug 16, 2022

BUY
$46.53 - $55.17 $9.57 Million - $11.3 Million
205,639 Added 17.28%
1,395,555 $73.2 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $7.85 Million - $9.73 Million
171,622 Added 16.85%
1,189,916 $61.6 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $4.37 Million - $6.48 Million
105,796 Added 11.59%
1,018,294 $60.1 Million
Q3 2021

Nov 16, 2021

BUY
$39.25 - $50.42 $5.43 Million - $6.97 Million
138,290 Added 17.86%
912,498 $39.2 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $392,711 - $444,876
10,936 Added 1.43%
774,208 $30.3 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $2.9 Million - $3.27 Million
86,612 Added 12.8%
763,272 $27.7 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $1.27 Million - $1.61 Million
37,930 Added 5.94%
676,660 $24.9 Million
Q3 2020

Nov 17, 2020

SELL
$31.75 - $37.25 $1.53 Million - $1.79 Million
-48,080 Reduced 7.0%
638,730 $23.2 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $1.36 Million - $1.65 Million
45,056 Added 7.02%
686,810 $23.2 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $1.13 Million - $1.61 Million
-41,655 Reduced 6.1%
641,754 $20.4 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $6.68 Million - $7.58 Million
202,960 Added 42.24%
683,409 $26.7 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $687,390 - $891,344
21,157 Added 4.61%
480,449 $17.3 Million
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $2.53 Million - $2.85 Million
68,542 Added 17.54%
459,292 $19.9 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $2.25 Million - $2.47 Million
59,892 Added 18.1%
390,750 $16.6 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $707,540 - $806,673
-18,392 Reduced 5.27%
330,858 $14.4 Million
Q3 2018

Nov 15, 2018

BUY
$34.47 - $41.81 $3.36 Million - $4.07 Million
97,351 Added 38.65%
349,250 $15.4 Million
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $403,378 - $430,041
12,231 Added 5.1%
251,899 $9.14 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $255,631 - $296,567
-8,011 Reduced 3.23%
239,668 $8.4 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $3.23 Million - $3.43 Million
97,080 Added 64.46%
247,679 $8.97 Million
Q3 2017

Feb 16, 2018

BUY
$31.0 - $34.15 $3.85 Million - $4.24 Million
124,239 Added 471.32%
150,599 $5.26 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $39,401 - $43,404
1,271 Added 5.07%
26,360 $941,000
Q2 2017

Nov 13, 2017

BUY
N/A
25,089
25,089 $843,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.